Michael Tadross is an assistant professor of biomedical engineering at Duke University, where he develops genetically encoded technologies to target clinically relevant drugs to specific cell types in the brain. His lab applies these methods to mouse models of neuropsychiatric disease, providing a roadmap for development of targeted therapeutics. He received a BS in electrical and computer engineering with a minor in chemistry from Rutgers University and an MD-PhD in biomedical engineering from Johns Hopkins University. He undertook postdoctoral training in cellular neuroscience with Richard Tsien at Stanford University and began independent research as a Fellow at the HHMI Janelia Research Campus. He now leads a project in the laboratory of Nicole Calakos.